I have had my saline implants for 12 years, in the last year I was diagnosed with cronic low WBC. Today I am going to an ENT because my voice has been horse (sp) for the last 3 months. I would love to have my implants removed and would like insurance to pay for some/most of the cost. Does anyone know how that would work?
Hello everyone, I was doing some research about breast implants when I came across this website. I am 17 years old and I’ve always wanted breast implants, I have a natural B cup but I’ve always desired more than that, I recently talked about it to my parents and they agreed to let me do it but not until my 18th birthday. After reading about it on this website I am starting to have second thoughts and questioning whether or not I should undergo this procedure. I’ve previously been diagnosed with colitis back in 2011 and I sure enough do not want any additional health issues after having implants. Is saline safer, or should I just steer clear of getting breast implants? Also, my mom has had implants since 2001, she has recently been diagnosed with rheumatoid arthritis and I’m starting to suspect the cause are her implants, she also has frequent chest pain. I’m very worried any help would be greatly appreciated.
Does insurance cover explantation? I want mine removed. I was diagnosed with Lupus and Rheumatoid Arthritis 3 months ago but have been dealing with symptoms for over 2 years. I’ve had my saline implants for 7 years now. I also feel as if milk wants to come out of my breasts. This has been going on for over a year on and off. My hormones were checked and were normal. I have severe daily headaches, memory loss, exhaustion, and jointand muscle pain. I truly feel something is up with these implants. I just don’t know if docs can even do a specific test to see if the implants are causing anything. I just want them out but sadly it costs more for explantation than it did to get them in.
Hi Thanks for this website. I need some support as I am really sick from these silicone implants I had put in around 22 years ago. All within the last 10 years I got endometrioisis, infertility, cystitis, chronic fatigue, muscle pain, myofascial pain, flu like symptoms, days of flare ups, very depressed state and muscle spasms all over my body. I have been eating really clean and supplements. The thought of exercise is unbearable. I’m scheduled for an explant next Friday the 20th of May. I cannot wait. My health has gone down hill quickly since November of 2015. I feel like my body is dying and the surgeon I am going to is very skilled in removing implants Enbloc way. But she does not think they are making me sick since the FDA sucks! So I had to wait 3 months for this appointment. People need to be more aware that theses implants do some serious damage to the human body. I’m hoping I feel healthy and all these problems go away after I remove them.
Bravo!! Yes, please go ahead and use any of my info and site name on your website. Do whatever you can to spread the word to as many ladies as we can. Thank you and much love, Nicole
The objective of the cost matrix was to estimate the cost of typical prosthetic device systems used by survey participants. We found that this cost depends on three characteristics: the type of prosthetic device (by varying degrees of technology), the level of limb loss, and the functional capability. For lower-limb loss, more than 400 unique prosthetic-device-type cost scenarios exist, predicated on six major prosthetic device types, seven limb-loss levels, and seven functional capability levels. The first important characteristic influencing cost is the type of prosthetic device system. Therefore, the first step was to categorize prosthetic devices within a group sharing a similar level of technology. Given the wide range of prosthetic devices and suppliers, it was impractical to attempt specific identification of each component or supplier for a prosthetic device for each survey participant. In lieu of specific device identification and costing, the survey grouped prosthetic devices into categories appropriate to prosthetic component technology. These six "prosthetic device types" for lower-limb loss devices included microprocessor, hybrid, mechanical, sports/specialty, waterproof, and cosmetic.
The third cost characteristic is the functional capability of the person with limb loss and the types of activities done in daily life. Functional capability plays a significant role in the cost of the components used to create a prosthetic device system. In addition, for those whose daily living activities include high-impact occupational or recreational activities, we found that not only were more devices used but also a wider diversity of prosthetic devices was in use.
The last step in developing the cost matrix was to estimate total costs based on the three cost characteristics. The costs for transtibial and transfemoral levels were determined by assigning Medicare L-codes appropriate for prosthetic device type, limb-loss level, and functional level. The cost for each L-code was assigned using the median Medicare cost for the 50 states and the District of Columbia. Our cost reference was the "Fee Schedule Update for 2005 for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)" for noninstitutional providers .
provides the specific L-codes, descriptions, and 2005 Medicare costs for typical components of a microprocessor knee at the transfemoral level to illustrate the process. The total cost of a prosthetic device system is $45,563.17. The cost matrix for transfemoral-level limb loss is shown in : the compiled cost is at the junction of the participant's functional capability (rows) and the type of prosthetic device (columns). We developed a cost matrix for each level of limb loss (data not shown). The cost for the prosthetic device described in is found in the microprocessor column in for functional levels 4 to 7. No costs are assigned for microprocessor devices at the transfemoral level at lower functional levels, because these devices are not used for nonambulatory or household walkers (according to the opinions of the expert panel).
For each survey participant, we accumulated the estimated costs over time for all devices used. This total cost is based on the number of past and current prosthetic devices reported in the survey and on the application of costs from the cost matrix (based on prosthetic device type, level of limb loss, and functional capability). For modeling purposes, total costs were stratified by combat cohorts (Vietnam and OIF/OEF) and the following limb-loss groups: unilateral lower, unilateral upper, bilateral upper, and multiple limb loss.
Markov models, commonly used in chronic disease research, were used to make cost projections over four different time horizons associated with limb loss: 5 years, 10 years, 20 years, and lifetime (up to 100 years) [18-22]. Our cost analysis included only the projected costs of prosthetic devices and assistive devices. The model estimates did not include costs for repair and increases in costs due to future technologies. Therefore, these cost estimates are conservative.
In defining our model, we used the set of principles for cost-effectiveness analysis developed by Weinstein et al. . Our Markov models consist of four basic components: (1) a basic model structure known as the cycle tree; (2) functional states (the functional levels) with corresponding prosthetic cost distributions; (3) transition probabilities, modeling the likelihood of a survey participant moving from one functional state to another over time; and (4) prosthetic and assistive device assumptions. Methodological details of each component of the models follow.